Acute will be a few hours.
Chronic will be days/weeks.
Re: SSH. I feel that this is going to continue to be painfully slow.
I feel that, based off how many people are dying (and all cause mortality usually an end point for a trial) we're unlikely succeed in Interim Analysis unless they can get the device in less sick people.
When everyone is dying it will be much harder to hit a 'very strict' P value on end points like what would be required for the interim analysis.
Even if the Interim Analysis fails, you can see there is definitely a space in the market for an EABP device, it just will probably never be C-pulse 1, but C-Pulse 2. So, so long as C-Pulse gets approval (eventually as I feel it's 100% likely to do) all we need is the FDA to allow for a small safety trial to prove that C-Pulse 2 is safe. The FDA shouldn't require a full phase 3 trial as the effect on the aorta will be the same between the 2 devices.. Therefore if C-Pulse 1 is medically effective, C-Pulse 2 is automatically proven to be too.
As such, I see the HUGE commercialisation coming in like 2018/2019. With very few C-Pulse 1's sold but hundred into thousands of C-Pulse 2's being sold. I think we'll go 1-2 billion plusaround that time. As long as we're sub 100 million shares on issue at that stage, we'll end up 10-20 dollars US minimum....
If the potential takes us to 3-4 billion... And we only have 50 million on issue, we're looking at 60-80 USD by 2019-2020.
Either way I feel that C-Pulse still has good potential but requires a lot of patience. I've gone from being like 50% of my portfolio in SSH down to about 10%... So it's still a big investment but no longer a 'make or break' for me.
The dilution risk keeps me at this size. Say this is still at 4-6 dollars in a year and a half, C-Pulse 2 is at first in man, C-Pulse 1 continues to have no exit-site infection and continues to prove its efficacy in Germany, I may up my investment 3 to 5 to 10 fold then.
Until then, patience is a virtue.
- Forums
- ASX - By Stock
- SHC
- 1st Qtr Report
1st Qtr Report, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online